A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

NCT03960814 · clinicaltrials.gov ↗

COMPLETED

Status

12847

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin detemir

Sponsor

Novo Nordisk A/S